Clinical trial
Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role…
NCT00169624 · Hospices Civils de Lyon, Other · Terminated
Key facts
| NCT number | NCT00169624 |
|---|---|
| Title | Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin |
| Official title | The DIAMET Study: Peripheral and Coronary Endothelial Dysfunction in Type 2diabetic Patients- Evaluation of Reversibility Following 3 Months of Metformin Treatment |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Coronary and Peripheral Endothelial Dysfunction |
| Intervention type | Drug |
| Interventions | Metformin, Gliclazide |
| Enrollment | 30 |
| Start date | Oct 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 5, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: